Type of diabetes-Type 2 - Page 2 of 13 Posts on Medivizor
Navigation Menu

Type of diabetes-Type 2 Posts on Medivizor

Evaluating symptoms of anxiety and depression in patients with diabetes mellitus

Posted by on Aug 25, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study investigated how common symptoms of anxiety and depression are amongst patients with diabetes mellitus. This study concluded that 1 in 10 patients had symptoms of both anxiety and depression. Some background Depression is nearly twice as common in adults with diabetes compared to the general population. Approximately 1 in 5...

Read More

Can succinate levels in the blood indicate remission of Type 2 diabetes?

Posted by on Aug 25, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study examined if the levels of succinate in the blood could indicate remission of Type 2 diabetes (T2D) in patients that had bariatric surgery. The authors found that succinate levels were lower in patients who achieved remission of T2D after surgery. Some background One of the main goals of treatment for T2D is to lower...

Read More

Can linagliptin improve glucose control in older people with type 2 diabetes?

Posted by on Aug 18, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study examined if linagliptin (Tradjenta) was safer and more effective in older patients with Type 2 diabetes compared to a placebo. This study concluded that linagliptin helped improve glucose control for these patients without causing additional side effects. Some background About 90% of diabetes cases are of Type 2 diabetes...

Read More

Looking for patients with type 2 diabetes and high cholesterol to test a cholesterol-reducing drug combination

Posted by on Aug 14, 2019 in Diabetes mellitus | 0 comments

In a nutshell This trial is examining how effective the drug bempedoic acid is when used with ezetimibe (Zetia) to reduce cholesterol in patients with type 2 diabetes (T2D). The main outcome will be the measurement of patient’s cholesterol as well as heart disease risk, diabetes severity and drug side effects. This study is recruiting in...

Read More

Assessment of new predictors of kidney disease in patients with type 2 diabetes

Posted by on Aug 10, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the accuracy of four new predictors of kidney damage and disease are compared to the standard test for patients with Type 2 diabetes (T2D). The authors found that these new predictors were as accurate as the standard test at detecting kidney disease. Some background Many patients with Type 2 diabetes (T2D)...

Read More

SGLT-2 inhibitors and lower limb amputation risk in people with type 2 diabetes

Posted by on Jul 29, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study wanted to find out if treating type 2 diabetes with SGLT-2 inhibitors increases the risk of disease in blood vessels or the risk of amputation of the feet. The study found that treating type 2 diabetes with certain SGLT-2 inhibitors such as canagliflozin (Invokana) may be associated with an increased risk of disease in the...

Read More

Efficacy and safety of basal-bolus insulin vs glp-1 receptor agonist plus basal insulin in patients with uncontrolled type 2 diabetes

Posted by on Jun 27, 2019 in Diabetes mellitus | 0 comments

In a nutshell This article compared the safety and effectiveness of insulin detemir (Levemir) plus liraglutide (Victoza) vs insulin detemir plus insulin aspart (Novolog) in the management of type 2 diabetes (T2D). The authors concluded that detemir plus liraglutide is a safe and more...

Read More

Ipragliflozin versus metformin for blood sugar control and fat reduction in type 2 diabetes

Posted by on May 17, 2019 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to compare the effectiveness of ipragliflozin compared to metformin in improving blood sugar control and reducing fat on organs in patients with type 2 diabetes (T2D) treated with sitagliptin. The main finding of the study was that ipragliflozin had greater reductions in fat but metformin had better blood sugar...

Read More

Evaluating the safety and effectiveness of pioglitazone in type 2 diabetes

Posted by on Apr 24, 2019 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to investigate the safety and effectiveness of pioglitazone in the treatment of type 2 diabetes (T2D). The main finding of the study was that pioglitazone was an effective treatment of T2D. Some background Insulin is the hormone that controls blood sugar. In T2D, patients have insulin resistance. This means that...

Read More